Health Care

Atropine plus patching increases visual acuity in amblyopic eyes

(HealthDay)—For children with severe amblyopia, combined atropine and patching therapy (CAPT) results in greater mean improvement of amblyopic eye visual acuity (VA) compared with patching alone, according to a study published online July 15 in JAMA Ophthalmology.

Shu Wang, M.D., from Fudan University in Shanghai, and colleagues compared the efficacy of CAPT versus patching alone for six months in children aged 3 to 12 years with severe amblyopia resulting from strabismus, anisometropia, or both. Overall, 53 and 55 children were randomly assigned to CAPT and patching therapy, respectively.

The researchers found that at six months, the mean improvement in amblyopic eye VA was 0.72 and 0.58 logMAR (7.2 versus 5.8 lines) for CAPT and patching alone, respectively (difference, 0.14 logMAR [1.4 lines]). At three months, the amblyopic eye VA improvement in the CAPT group was also greater than in the patching alone group (difference, 0.13 logMAR [1.3 lines]). None of the participants withdrew due to adverse effects.

“The current study indicates that both the CAPT and patching alone therapy were efficacious for children aged 3 to 12 years with severe amblyopia,” the authors write. “CAPT resulted in more mean improvement of amblyopic eye VA than patching alone, although the differences were relatively small and the clinical relevance of this difference cannot be determined by this trial.”


Amblyopia Tx at young age results in good vision later


More information:
Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Copyright © 2021 HealthDay. All rights reserved.

Citation:
Atropine plus patching increases visual acuity in amblyopic eyes (2021, July 15)
retrieved 16 July 2021
from https://medicalxpress.com/news/2021-07-atropine-patching-visual-acuity-amblyopic.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.



 Source link

Back to top button